- The microbiome: an integral player in immune homeostasis and inflammation in the respiratory tract
Olaf Perdijk et al, 2024, Physiological Reviews CrossRef - Biological Evaluation of Chinese Herbal Compounds as Anticancer Agents in Fighting Against Lung Cancer
Xi Zhao et al, 2022, International Journal of Pharmacology CrossRef - Acute Effects of Heated Tobacco Product (IQOS) Aerosol Inhalation on Lung Tissue Damage and Inflammatory Changes in the Lungs
Tariq A Bhat et al, 2021, Nicotine & Tobacco Research CrossRef - Intratumoral Microbiota-Host Interactions Shape the Variability of Lung Adenocarcinoma and Lung Squamous Cell Carcinoma in Recurrence and Metastasis
Xiangfeng Zhou et al, 2023, Microbiology Spectrum CrossRef - Restoration of Peripheral Intermediate and Classical Monocytes Expressing HLA-DR in Patients With Lung Adenocarcinoma After Platinum-Based Chemotherapy
Selma Rivas-Fuentes et al, 2018, Technology in Cancer Research & Treatment CrossRef - IL-17-Producing Cells in Tumor Immunity: Friends or Foes?
Da-Sol Kuen et al, 2020, Immune Network CrossRef - PD-L1 expression indicates favorable prognosis for advanced lung adenocarcinoma patients treated with pemetrexed
Pei Zhang et al, 2017, Oncotarget CrossRef - Commensal Microbiota Promote Lung Cancer Development via γδ T Cells
Chengcheng Jin et al, 2019, Cell CrossRef - IL-17 Cytokines and Chronic Lung Diseases
Felix Ritzmann et al, 2022, Cells CrossRef - Evaluation of IL-17A expressions in high-grade glial tumors receiving radiotherapy
F Karaca et al, 2022, Nigerian Journal of Clinical Practice CrossRef - Long‐term prognostic significance of interleukin‐17‐producing T cells in patients with non‐small cell lung cancer
Li Song et al, 2019, Cancer Science CrossRef - Lung microbiome: an emerging player in lung cancer pathogenesis and progression
Alexandra Karvela et al, 2023, Clinical and Translational Oncology CrossRef - The Influence of Lung Microbiota on Lung Carcinogenesis, Immunity, and Immunotherapy
Ariel G. Ramírez-Labrada et al, 2020, Trends in Cancer CrossRef - The Lung Microbiome: A Central Mediator of Host Inflammation and Metabolism in Lung Cancer Patients?
Frank Weinberg et al, 2020, Cancers CrossRef - Acidovorax temperans skews neutrophil maturation and polarizes Th17 cells to promote lung adenocarcinoma development
Joshua K. Stone et al, 2024, Oncogenesis CrossRef - Emerging cellular and molecular interactions between the lung microbiota and lung diseases
Li Xiang et al, 2022, Critical Reviews in Microbiology CrossRef - Countering the advert effects of lung cancer on the anticancer potential of dendritic cell populations reinstates sensitivity to anti-PD-1 therapy
Julyanne Brassard et al, 2021, PLOS ONE CrossRef - Tregitopes Improve Asthma by Promoting Highly Suppressive and Antigen-Specific Tregs
Marieme Dembele et al, 2021, Frontiers in Immunology CrossRef - Liposomal Co-delivery of PD-L1 siRNA/Anemoside B4 for Enhanced Combinational Immunotherapeutic Effect
Xiang Li et al, 2022, ACS Applied Materials & Interfaces CrossRef - Inhaled IL-10 Suppresses Lung Tumorigenesis via Abrogation of Inflammatory Macrophage–Th17 Cell Axis
Qingsheng Li et al, 2018, The Journal of Immunology CrossRef - Targeting interleukin-17 in radiation-induced toxicity and cancer progression
Piyush Baindara, 2024, Cytokine & Growth Factor Reviews CrossRef - The Lung Microbiome in Carcinogenesis and Immunotherapy Treatment
Kathleen Kennedy et al, 2023, The Cancer Journal CrossRef - Glycomic Signatures of Plasma IgG Improve Preoperative Prediction of the Invasiveness of Small Lung Nodules
Xia Zou et al, 2019, Molecules CrossRef - Preclinical Evidence for Combined Use of Aromatase Inhibitors and NSAIDs as Preventive Agents of Tobacco-Induced Lung Cancer
Laura P. Stabile et al, 2018, Journal of Thoracic Oncology CrossRef - Loss of miR‐146b‐5p promotes T cell acute lymphoblastic leukemia migration and invasion via the IL‐17A pathway
Zhenbo Tu et al, 2019, Journal of Cellular Biochemistry CrossRef